Literature DB >> 9041675

Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line.

S Krusekopf1, U Kleeberg, A G Hildebrandt, K Ruckpaul.   

Abstract

1. Induction of endogenous cytochrome P4501A1 (CYP1A1) by benzimidazole derivatives has been investigated in the human hepatoma cell line HepG2. 2. By Northern and Western blot analysis, omeprazole has been shown to be a more potent inducer of CYP1A1 than both lansoprazole and E3810, whereas pantoprazole did not induce CYP1A1. Similar results were obtained for the CYP1A1 enzyme-specific deethylation of 7-ethoxyresorufin. 3. The induction of CYP1A1 in the permanent cell line HepG2 corresponds to results observed in human hepatocytes in primary culture. 4. The results provide experimental evidence that HepG2 cells can be used as an appropriate tool to examine inducing effects of drugs on the expression of CYP1A1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041675     DOI: 10.1080/004982597240721

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes.

Authors:  Binoy Shivanna; Weiwu Jiang; Lihua Wang; Xanthi I Couroucli; Bhagavatula Moorthy
Journal:  J Pharmacol Exp Ther       Date:  2011-07-18       Impact factor: 4.030

Review 2.  CYP induction-mediated drug interactions: in vitro assessment and clinical implications.

Authors:  Jiunn H Lin
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

3.  Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.

Authors:  Carolina Alves Nicolau; Alyson Prorock; Yongde Bao; Ana Gisele da Costa Neves-Ferreira; Richard Hemmi Valente; Jay William Fox
Journal:  Toxins (Basel)       Date:  2018-02-06       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.